Showing results (1-10 of 179) with videos related to
Sort By:
Pageof 18
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 25, 2014
[Targeting the PD-1/PD-L1 immune checkpoint signal - a new treatment strategy for cancer]Junzo Hamanishi, Ikuo KonishiNihon Rinsho. Japanese Journal of Clinical Medicine|December 19, 2018
Immune checkpoint (PD-1 and CTIA-4) signal inhibitors for gynecologic oncology; up to dateJunzo Hamanishi, Masaki Mandai, Ikuo KonishiGan to Kagaku Ryoho. Cancer & Chemotherapy|October 6, 2025
[Clinical Significance and Therapeutic Applications of Tertiary Lymphoid Structures(TLS)in Gynecological Cancers]Junzo Hamanishi, Kohei Hamada, Masaki MandaiInternational Immunology|April 9, 2016
Immune checkpoint inhibition in ovarian cancerJunzo Hamanishi, Masaki Mandai, Ikuo KonishiGynecologic Oncology|September 16, 2018
Genomics to immunotherapy of ovarian clear cell carcinoma: Unique opportunities for managementKatsutoshi Oda, Junzo Hamanishi, Koji Matsuo, et al.Journal of Biomedical Science|April 6, 2017
Cancer immunotherapies targeting the PD-1 signaling pathwayYoshiko Iwai, Junzo Hamanishi, Kenji Chamoto, et al.British Journal of Cancer|September 6, 2022
Dynamic host immunity and PD-L1/PD-1 blockade efficacy: developments after "IFN-γ from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer"Kaoru Abiko, Junzo Hamanishi, Noriomi Matsumura, et al.Case Reports in Obstetrics and Gynecology|July 2, 2020
Two Cases of Ectopic Pregnancy Mimicking Gestational Trophoblastic DiseaseHaruka Suzuki, Yoshitsugu Chigusa, Junzo Hamanishi, et al.Surgery Journal (New York, N.Y.)|February 3, 2022
Superradical Hysterectomy for Cervical Cancer as an Alternative to the Usual Okabayashi-Type Radical HysterectomyMasaki Mandai, Ken Yamaguchi, Junzo Hamanishi, et al.International Journal of Clinical Oncology|February 23, 2016
PD-1/PD-L1 blockade in cancer treatment: perspectives and issuesJunzo Hamanishi, Masaki Mandai, Noriomi Matsumura, et al.Pageof 18